7. Traditional Chinese medicine intervention and prevention of precancerous diseases of the digestive system
Release time:
2023-05-30 11:04
Early cancer of the digestive tract has gradually received widespread attention from the world in recent years.It is often emphasized that“discovering a case of early cancer saves a family”,which shows that the diagnosis and treatment of early cancer of the digestive tract is not only of great significance to gastroenterology,but also to patients and even the patient's family.Of great significance.The Department of Spleen and Gastrointestinal Diseases not only focuses on the inheritance and continuation of traditional Chinese medicine diagnosis and treatment,but also keeps up with the cutting-edge technological development of gastroenterology in the world,actively learns advanced academic perspectives,develops endoscopic diagnosis and treatment techniques,and conducts a lot of scientific research.:
1.Exploring the Pharmacological Mechanism of the Herb Pair"HuangLian-GanJiang"against Colorectal Cancer Based on Network Pharmacology
2.Effects of SOCS3 on the development of colon cancer via regulation of HIF-1α
3.Long non-coding RNA HIT000218960 is associated with poor prognosis in patients with gastric cancer
4.lncRNA HIT000218960 enhances resistance to 5-fluorouracil by promoting HMGA2 and activating the AKTmTORP70S6K pathway in gastric cancer cells
5.Exploring the Pharmacological Mechanism of the Herb Pair"HuangLian-GanJiang"against Colorectal Cancer Based on Network Pharmacology
6.Identification of Hub Genes Related to Carcinogenesis and Prognosis in Colorectal Cancer Based on Integrated Bioinformatics
7.Systematic Investigation of Scutellariae Barbatae Herba for Treating Hepatocellular Carcinoma Based on Network Pharmacology
8.Research progress on the relationship between intestinal flora disorders and spleen deficiency colorectal cancer
